Current State And Trends In The Incidence Of Chronic Kidney Disease Among Adult Population And Opportunities For Its Prevention And Treatment In Moscow Healthcare Organizations

Introduction. Currently, the incidence of kidney diseases among adult population is growing. It is expected to become the fifth leading cause of death by 2040. Showing no symptoms at early stages, chronic kidney disease (CKD) is closely related to diabetes mellitus, hypertension, obesity and kidney dysfunction in older age, which requires long-term and expensive treatment. Organization structure and the strategy of medical care provided by Moscow nephrology service is aimed at implementing measures for risk prevention and active early detection of kidney disease, as well as informing general population and medical community about existing diagnostic methods, modern treatment options and schemes.

The purpose of the study was to identify trends in CKD prevalence and incidence among able-bodied population in the context of Moscow nephrology service improvement.

Materials and Methods. An analysis of disease prevalence and incidence among able-bodied population based on official statistics data of the Russian Research Institute of Health (RIH) of the Ministry of Health of the Russian Federation and the Centre of Medical Statistics of Moscow Healthcare Department was carried out; indicators of time series and average growth/decrease rates were calculated. In order to identify a long-term trend, least squares method was used. Incidence rates were expressed per 100,000 able-bodied population.

Results. In 2022, the overall disease prevalence in Moscow was lower than for the country as a whole (31.3 and 74.2 cases per 100,000 population, respectively), while incidence of the able-bodied population in Moscow was lower than countrywide (2.9 and 11.5 cases per 100,000 population, respectively). The long-term dynamics of CRD prevalence and incidence was generally characterized by an upward trend. Thus, the average annual incidence in Moscow was 9.8% and 6.1%, while in the Russian Federation 7.2% and 5.4%, respectively. On average, 91.3% of able-bodied patients with CKD in Moscow are under follow-up monitoring for a year. The number of dispensary patients with CKD increased by 2.5 times in 2022 in comparison to 2013, from 11.7 to 29.5 per 100,000 population, respectively. Since 2016, patients with newly diagnosed CKD have been provided with 100% coverage of follow-up monitoring.

1. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Kidney international. 2019 Nov;96(5):1048-1050. doi: 10.1016/j.kint.2019.07.012.

2. McKinley, J. M., Mueller, U., Atkinson, P. M., Ofterdinger, U., Cox, S. F., Doherty, R., Fogarty, D., Egozcue, J. J., Pawlowsky-Glahn, V. Chronic kidney disease of unknown origin is associated with environmental urbanisation in Belfast, UK. Environmental geochemistry and health. 2021 Jul;43(7):2597–2614. doi.org/10.1007/s10653-020-00618-y.

3. Ranasinghe, A. V., Kumara, G. W. G. P., Karunarathna, R. H., De Silva, A. P., Sachintani, K. G. D., Gunawardena, J. M. C. N., Kumari, S. K. C. R., Sarjana, M. S. F., Chandraguptha, J. S., & De Silva, M. V. C. The incidence, prevalence and trends of Chronic Kidney Disease and Chronic Kidney Disease of uncertain aetiology (CKDu) in the North Central Province of Sri Lanka: an analysis of 30,566 patients. BMC nephrology. 2019 Aug;20(1), 338. doi.org/10.1186/s12882-019-1501-0.

4. Shamkhalova M.S., Vikulova O.K., Zheleznyakova A.V., Isakov M.A., Shestakova M.V., Dedov I.I. Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016). Diabetes mellitus. 2018;21(3):160-169.

5. Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Zh.A., Astanin P.A., Yusupova T.F., Yusupov F.A. Kidney damage in hypertension disease. Clinical Medicine (Russian Journal). 2023;101(11):569-576. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-11-569-576

6. Shilov E.M., Shilova M.M., Rumyantseva E.I., Yesayan A.M., Kotenko O.N. The state of the nephrological service in the Russian Federation: renal replacement therapy in the period from 2017 to 2021. Clinical Nephrology. 2022; 14 (1). https://doi.org/10.18565/nephrology.2022.1.6-15

7. Feng, T., Xu, Y., Zheng, J., Wang, X., Li, Y., Wang, Y., Zhu, B., Zhao, L., Zhao, H., & Yu, J. Prevalence of and risk factors for chronic kidney disease in ten metropolitan areas of China: a cross-sectional study using three kidney damage markers. Renal failure. 2023 Jan;45(1): doi.org/10.1080/0886022X.2023.2170243

8. Harris DCH, et al. Increasing access to integrated ESKD care as part of universal health coverage. Kidney international. 2019 Apr;95:S1–S33. doi: 10.1016/j.kint.2018.12.005.

9. Tonelli, M., & Dickinson, J. A. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries. Journal of the American Society of Nephrology. 2020 Sep;31(9):1931–1940. doi.org/10.1681/ASN.2020030277

10. Nagib, S. N., Abdelwahab, S., Amin, G. E. E., & Allam, M. F. Screening and early detection of chronic kidney disease at primary healthcare. Clinical and experimental hypertension (New York, N.Y. : 1993). 2021 Mar;43(5), 416–418. doi.org/10.1080/10641963.2021.1896726

11. Luyckx, V. A., Cherney, D. Z. I., & Bello, A. K. (2019). Preventing CKD in Developed Countries. Kidney international reports. 2022 Jun;5(3), 263–277. doi.org/10.1016/j.ekir.2019.12.003

12. Lassalle, M., Monnet, E., Ayav, C., Hogan, J., Moranne, O., Couchoud, C. 2017 Annual Report Digest of the Renal Epidemiology Information Network (REIN) registry. Transplant international: official journal of the European Society for Organ Transplantation. 2019 May;32(9), 892–902. doi.org/10.1111/tri.13466

13. Shlipak, M. G., Tummalapalli, S. L., Boulware, L. E., Grams, M. E., Ix, J. H., Jha, V., Kengne, A. P., Madero, M., Mihaylova, B., Tangri, N., Cheung, M., Jadoul, M., Winkelmayer, W. C., Zoungas, S., The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2021 May;99(1), 34–47. doi.org/10.1016/j.kint.2020.10.012

14. Farrell, D. R., Vassalotti, J. A. Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? BMC nephrology. 2024 Jan:25(1), 34. doi.org/10.1186/s12882-024-03466-5

15. Pouwels, X. G. L. V., van Mil, D., Kieneker, L. M., Boersma, C., van Etten, R. W., Evers-Roeten, B., Heerspink, H. J. L., Hemmelder, M. H., Langelaan, M. L. P., Thelen, M. H. M., Gansevoort, R. T., Koffijberg, H. Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease. EClinicalMedicine. 2024 Feb;68, 102414. doi.org/10.1016/j.eclinm.2023.102414

16. Shin JI, Chang AR, Grams ME, et al. Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium. Hypertension. 2021 Aug;78(4):1042-1052. doi:10.1161/HYPERTENSIONAHA.121.17323

17. Savina A.A., Feyginova S.l. Dynamics in incidence of diseases of the circulatory system among adults in the Russian Federation in 2007-2019. Social’nye aspekty zdorov'a naselenia / Social aspects of population health [serial online] 2021; 67(1): 1. DOI 10.21045/2071-5021-2021-67-2-1 (In Russ.)

18. Savina AA. Trends in the incidence of diseases of the endocrine system of the adult population of the Russian Federation. Social'nye aspekty zdorov'a naselenia / Social aspects of population health [serial online] 2021; 67(4):6. DOI 10.21045/2071-5021-2021-67-4-6 (In Russ.)

19. Stempniewicz N, Vassalotti JA, Cuddeback JK, et al. Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations. Diabetes Care. 2021 Jul;44(9):2000-2009. doi:10.2337/dc20-2715

20. Charles, C., & Ferris, A. H. Chronic Kidney Disease. Primary care. 2020 Dec; 47(4), 585–595. doi.org/10.1016/j.pop.2020.08.001.

21. Vassalotti, J. A., Boucree, S. C. Integrating CKD Into US Primary Care: Bridging the Knowledge and Implementation Gaps. Kidney international Reports. 2022 Mar; 7(3), 389–396. doi.org/10.1016/j.ekir.2022.01.1066

22. Lee J, Chu C, Guzman D, et al. Albuminuria Testing by Race and Ethnicity among Patients with Hypertension with and without Diabetes. Am J Nephrol. 2019 Jun;50(1):48-54. doi:10.1159/000500706

23. Oude Engberink, A., Tessier, G., Kamil, I., Bourrel, G., & Moranne, O. General practitioners' representation of early-stage CKD is a barrier to adequate management and patient empowerment: a phenomenological study. Journal of nephrology. 2024 Jan. doi.org/10.1007/s40620-023-01838-y